{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:15:17Z","timestamp":1786986917013,"version":"build-2736575974"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography A"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.chroma.2019.06.022","type":"journal-article","created":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T11:03:28Z","timestamp":1560164608000},"page":"95-103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"special_numbering":"C","title":["Fully automated therapeutic drug monitoring of anti-epileptic drugs making use of dried blood spots"],"prefix":"10.1016","volume":"1601","author":[{"given":"Sofie","family":"Velghe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigrid","family":"Deprez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7126-348X","authenticated-orcid":false,"given":"Christophe P.","family":"Stove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chroma.2019.06.022_bib0005","doi-asserted-by":"crossref","first-page":"230","DOI":"10.3109\/10408444.2011.650790","article-title":"Dried blood spots in toxicology: from the cradle to the grave?","volume":"42","author":"Stove","year":"2012","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.chroma.2019.06.022_bib0010","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.4155\/bio.14.156","article-title":"Spot them in the spot: analysis of abused substances using dried blood spots","volume":"6","author":"Sadones","year":"2014","journal-title":"Bioanalysis"},{"key":"10.1016\/j.chroma.2019.06.022_bib0015","series-title":"Clinical Challenges in Therapeutic Drug Monitoring","first-page":"279","article-title":"Alternative sampling strategies for therapeutic drug monitoring","author":"Capiau","year":"2016"},{"key":"10.1016\/j.chroma.2019.06.022_bib0020","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.trac.2016.01.030","article-title":"Opening the toolbox of alternative sampling strategies in clinical routine: a key-role for (LC-)MS\/MS","volume":"84","author":"Velghe","year":"2016","journal-title":"Trac-Trends Anal. Chem."},{"key":"10.1016\/j.chroma.2019.06.022_bib0025","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1007\/s40262-014-0177-7","article-title":"Therapeutic drug monitoring by dried blood spot: progress to date and future directions","volume":"53","author":"Wilhelm","year":"2014","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.chroma.2019.06.022_bib0030","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.4155\/bio.14.149","article-title":"CYP1A2 phenotyping in dried blood spots and microvolumes of whole blood and plasma","volume":"6","author":"De Kesel","year":"2014","journal-title":"Bioanalysis"},{"key":"10.1016\/j.chroma.2019.06.022_bib0035","series-title":"Micro Sampling in Pharmaceutical Analysis","article-title":"Dried blood spots: the future","author":"Oliveira","year":"2013"},{"key":"10.1016\/j.chroma.2019.06.022_bib0040","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.4155\/bio.15.120","article-title":"DBS direct elution: optimizing performance in high-throughput quantitative LC-MS\/MS analysis","volume":"7","author":"Abu-Rabie","year":"2015","journal-title":"Bioanalysis"},{"key":"10.1016\/j.chroma.2019.06.022_bib0045","doi-asserted-by":"crossref","first-page":"11229","DOI":"10.1021\/acs.analchem.6b03691","article-title":"A book-type dried plasma spot card for automated flow-through elution coupled with online SPE-LC-MS\/MS bioanalysis of opioids and stimulants in blood","volume":"88","author":"Ryona","year":"2016","journal-title":"Anal. Chem."},{"key":"10.1016\/j.chroma.2019.06.022_bib0050","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.4155\/bio.11.159","article-title":"Direct analysis of DBS: emerging and desirable technologies","volume":"3","author":"Abu-Rabie","year":"2011","journal-title":"Bioanalysis"},{"key":"10.1016\/j.chroma.2019.06.022_bib0055","unstructured":"CAMAG. DBS-MS 500 [Available from: https:\/\/www.camag.com\/en\/dbs\/dbs-ms_500.cfm."},{"key":"10.1016\/j.chroma.2019.06.022_bib0060","unstructured":"Prolab. Scap system DBS [Available from: https:\/\/www.prolab.ch\/wp-content\/uploads\/SCAP-DBS-A4-6page-web.pdf."},{"key":"10.1016\/j.chroma.2019.06.022_bib0065","series-title":"DBSautosamplerTM","author":"Holland","year":"2019"},{"key":"10.1016\/j.chroma.2019.06.022_bib0070","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1002\/rcm.7033","article-title":"Automated high-capacity on-line extraction and bioanalysis of dried blood spot samples using liquid chromatography\/high-resolution accurate mass spectrometry","volume":"28","author":"Oliveira","year":"2014","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.chroma.2019.06.022_bib0075","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jchromb.2011.12.012","article-title":"Development and validation of a fully automated online human dried blood spot analysis of bosentan and its metabolites using the Sample Card and Prep DBS System","volume":"885-886","author":"Ganz","year":"2012","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.chroma.2019.06.022_bib0080","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/dta.1927","article-title":"Quantitative determination of opioids in whole blood using fully automated dried blood spot desorption coupled to on-line SPE-LC-MS\/MS","volume":"8","author":"Verplaetse","year":"2016","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.chroma.2019.06.022_bib0085","doi-asserted-by":"crossref","first-page":"4996","DOI":"10.1021\/acs.analchem.5b00908","article-title":"Investigation of different approaches to incorporating internal standard in DBS quantitative bioanalytical workflows and their effect on nullifying hematocrit-based assay bias","volume":"87","author":"Abu-Rabie","year":"2015","journal-title":"Anal. Chem."},{"key":"10.1016\/j.chroma.2019.06.022_bib0090","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.4155\/bio.14.162","article-title":"Automated direct extraction and analysis of dried blood spots employing on-line SPE high-resolution accurate mass bioanalysis","volume":"6","author":"Oliveira","year":"2014","journal-title":"Bioanalysis"},{"key":"10.1016\/j.chroma.2019.06.022_bib0095","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.4155\/bio.11.270","article-title":"Dried matrix spot direct analysis: evaluating the robustness of a direct elution technique for use in quantitative bioanalysis","volume":"3","author":"Abu-Rabie","year":"2011","journal-title":"Bioanalysis"},{"key":"10.1016\/j.chroma.2019.06.022_bib0100","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/jms.3952","article-title":"Automated high throughput analysis of antiretroviral drugs in dried blood spots","volume":"52","author":"Duthaler","year":"2017","journal-title":"J. Mass Spectrom."},{"key":"10.1016\/j.chroma.2019.06.022_bib0105","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jpba.2019.04.007","article-title":"Development and validation of an LC-MS\/MS method for the analysis of ivermectin in plasma, whole blood, and dried blood spots using a fully automatic extraction system","volume":"172","author":"Duthaler","year":"2019","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.chroma.2019.06.022_bib0110","doi-asserted-by":"crossref","DOI":"10.1093\/jat\/bkz035","article-title":"Fully automated determination of phosphatidylethanol 16:0\/18:1 and 16:0\/18:2 in dried blood spots","author":"Luginb\u00fchl","year":"2019","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.chroma.2019.06.022_bib0115","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1528-1167.2008.01561.x","article-title":"Antiepileptic drugs--best practice guidelines for therapeutic drug monitoring: a position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies","volume":"49","author":"Patsalos","year":"2008","journal-title":"Epilepsia."},{"key":"10.1016\/j.chroma.2019.06.022_bib0120","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2174\/1567201812666151029100909","article-title":"Consensus guideline based therapeutic drug monitoring (TDM) in psychiatry and neurology","volume":"13","author":"Hiemke","year":"2016","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.chroma.2019.06.022_bib0125","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.4155\/bio.10.103","article-title":"The effect of hematocrit on assay bias when using DBS samples for the quantitative bioanalysis of drugs","volume":"2","author":"Denniff","year":"2010","journal-title":"Bioanalysis"},{"key":"10.1016\/j.chroma.2019.06.022_bib0130","series-title":"Food and Drug Administration. Center for Drug Evaluation and Research (CDER). Center for Veterinary Medicine (CVM). Bioanalytical Method Validation - Guidance for Industry","author":"U.S. Department of Health and Human Services","year":"2018"},{"key":"10.1016\/j.chroma.2019.06.022_bib0135","series-title":"Guideline on Bioanalytical Method Validation","author":"European Medicines Agency","year":"2011"},{"key":"10.1016\/j.chroma.2019.06.022_bib0140","doi-asserted-by":"crossref","DOI":"10.1097\/FTD.0000000000000643","article-title":"Official international association for therapeutic drug monitoring and toxicology guideline: development and validation of dried blood sample-based methods for therapeutic drug monitoring","author":"Capiau","year":"2019","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.chroma.2019.06.022_bib0145","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00769-011-0775-0","article-title":"Practical aspects concerning validation and quality control for forensic and clinical bioanalytical quantitative methods","volume":"16","author":"Wille","year":"2011","journal-title":"Accredit. Qual. Assur."},{"key":"10.1016\/j.chroma.2019.06.022_bib0150","series-title":"CLSI Document EP05-A3: Evaluation of Precision of Quantitative Measurement Procedures; Approved Guideline\u2014Third Edition","author":"Clinical and Laboratory Standards Institute","year":"2014"},{"key":"10.1016\/j.chroma.2019.06.022_bib0155","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jchromb.2017.11.005","article-title":"Carbamazepine, lamotrigine, levetiracetam and valproic acid in dried blood spots with liquid chromatography tandem mass spectrometry; method development and validation","volume":"1072","author":"Linder","year":"2018","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.chroma.2019.06.022_bib0160","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jchromb.2013.02.005","article-title":"A simple bioanalytical method for the quantification of antiepileptic drugs in dried blood spots","volume":"923-924","author":"Shah","year":"2013","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.chroma.2019.06.022_bib0165","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.cca.2014.11.007","article-title":"Dried blood spot assay for the quantification of phenytoin using Liquid Chromatography-Mass Spectrometry","volume":"440","author":"Villanelli","year":"2015","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.chroma.2019.06.022_bib0170","doi-asserted-by":"crossref","first-page":"6789","DOI":"10.1021\/acs.analchem.6b01190","article-title":"Hematocrit-independent quantitation of stimulants in dried blood spots: pipet versus microfluidic-based volumetric sampling coupled with automated flow-through desorption and online solid phase extraction-LC-MS\/MS bioanalysis","volume":"88","author":"Verplaetse","year":"2016","journal-title":"Anal. Chem."},{"key":"10.1016\/j.chroma.2019.06.022_bib0175","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1007\/s00216-018-0866-4","article-title":"Volumetric absorptive microsampling as an alternative tool for therapeutic drug monitoring of first-generation anti-epileptic drugs","volume":"410","author":"Velghe","year":"2018","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.chroma.2019.06.022_bib0180","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.4155\/bio.13.156","article-title":"Hemato-critical issues in quantitative analysis of dried blood spots: challenges and solutions","volume":"5","author":"De Kesel","year":"2013","journal-title":"Bioanalysis"},{"key":"10.1016\/j.chroma.2019.06.022_bib0185","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s40263-013-0050-5","article-title":"Feasibility of following up gamma-hydroxybutyric acid concentrations in sodium oxybate (Xyrem(R))-treated narcoleptic patients using dried blood spot sampling at home: an exploratory study","volume":"27","author":"Ingels","year":"2013","journal-title":"CNS Drugs"},{"key":"10.1016\/j.chroma.2019.06.022_bib0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108190","article-title":"Clinical validation and implications of dried blood spot sampling of carbamazepine, valproic acid and phenytoin in patients with epilepsy","volume":"9","author":"Kong","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.chroma.2019.06.022_bib0195","doi-asserted-by":"crossref","DOI":"10.1097\/FTD.0000000000000605","article-title":"Dried blood spot self-sampling by guardians of children with epilepsy is feasible: comparison with plasma for multiple antiepileptic drugs","author":"Linder","year":"2019","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.chroma.2019.06.022_bib0200","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1111\/j.1528-1167.2009.02204.x","article-title":"A new rapid micromethod for the assay of phenobarbital from dried blood spots by LC-tandem mass spectrometry","volume":"50","author":"la Marca","year":"2009","journal-title":"Epilepsia."}],"container-title":["Journal of Chromatography A"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021967319306314?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021967319306314?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,24]],"date-time":"2019-07-24T09:48:23Z","timestamp":1563961703000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021967319306314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":40,"alternative-id":["S0021967319306314"],"URL":"https:\/\/doi.org\/10.1016\/j.chroma.2019.06.022","relation":{},"ISSN":["0021-9673"],"issn-type":[{"value":"0021-9673","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fully automated therapeutic drug monitoring of anti-epileptic drugs making use of dried blood spots","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography A","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chroma.2019.06.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}